未标题-7(1752192518211).jpg
+
  • 未标题-7(1752192518211).jpg

Amlodipine Maleate Dispersible Tablets

Belongs to Category:

The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.

Product Description

Approval Number:

H20080295

Indications:

1. Hypertension. This product can be used alone or in combination with other antihypertensive drugs.

2. Chronic stable angina pectoris and variant angina. This product can be used alone or in combination with other anti-anginal drugs.

Administration:

1. Treatment of hypertension:

The initial dose is 1 tablet (5mg) once daily, with a maximum dose of 2 tablets (10mg) once daily. For frail or elderly patients and patients with hepatic insufficiency, the initial dose is half a tablet (2.5mg) once daily. This dose can also be the dose required when adding this product to the treatment of other antihypertensive drugs.

The dose should be adjusted according to the patient's individual response: General dose adjustments should be started after 7-14 days. If clinically necessary, dose adjustments can be started in a shorter period under close monitoring of the patient.

2. Treatment of angina pectoris:

The initial dose is 1-2 tablets (5-10mg) once daily. Lower doses are recommended for elderly and patients with hepatic insufficiency. The effective dose for most people is 2 tablets (10mg)/day.

Specifications:

5mg × 14 tablets

The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.

The main products cover cardiovascular diseases, diabetic complications, anti-tumor, calcium supplementation, digestive system, respiratory system, and orthopedics.

Online Message

We will contact you within one business day. Please pay attention to your email.

Submit

Email: marcos.yuan@wangao.com.cn

Address: No. 688, Dinghai Road, Haimen City, Jiangsu Province

 

Wangao Pharmaceutical

Mobile Version QR Code

Wangao Pharmaceutical

WeChat Official Account


Copyright © 2025 Jiangsu Wangao Pharmaceutical Co., Ltd.

Business License